Registered User Login
Asian Journal of Research in Pharmaceutical Sciences
ISSN: 2231-5659(Online), 2231-5640(Print)
News & Conferences
Volume No. :
Issue No. :
ISSN Print :
ISSN Online :
Click to Login
Dealing With the Challenges during Large Scale Manufacturing of Polymorphic Drug Substances
Sudhir Sawant* and Ramesh Yamgar
P. G. Dept of Chemistry, Govt. of Maharashtra’s Ismail Yusuf College of Arts, Science and Commerce, Jogeshwari (East), Mumbai 400 060 INDIA
This paper will discuss the various risks and challenges that manufacturers face regarding the manufacturing of polymorphically pure products especially APIs and detailed specific risks during manufacturing in commercial plants and precautions to be taken during manufacturing, quality inspections and also during their product development efforts in R and D. A conscious approach of all personnel involved in manufacturing teams towards ensuring the polymorphic purity of the drug substance is very much essential element for regulated markets and for business continuity of a generic firm.
Polymorphs, drug substance, bioavailability, bioequivalence, dissolution, recrystallisation, XRPD, manufacturing, regulatory agencies, DMF, ANDA
Sudhir Sawant, Ramesh Yamgar. Dealing With the Challenges during Large Scale Manufacturing of Polymorphic Drug Substances. Asian J. Res. Pharm. Sci. 1(3): July-Sept. 2011; Page 63-68.
Visitor's No. :